Minerva Neurosciences Inc (NASDAQ:NERV)
| 9.23 Delayed Data As of Feb 19 |  +0.15 / +1.65%Today’s Change | 4.01 Today|||52-Week Range 9.56 | +29.82% Year-to-Date |
Latest NERV News | Press Releases
No recent news for Minerva Neurosciences Inc.
Today’s Trading
| Previous close | 9.08 |
| Today’s open | 9.14 |
| Day’s range | 9.14 - 9.56 |
| Volume | 636,082 |
| Average volume (3 months) | 388,734 |
| Market cap | $340.3M |
Data as of 3:59pm ET, 02/19/2020
Growth & Valuation
| Earnings growth (last year) | -55.82% |
| Earnings growth (this year) | -13.58% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STMLStemline Therapeutic... | +0.19 | +2.70% |
| TCRRTCR2 Therapeutics In... | +0.24 | +1.64% |
| GRTSGritstone Oncology I... | +0.19 | +1.89% |
| CTMXCytomX Therapeutics ... | -0.37 | -4.86% |
Data as of 4:00pm ET, 02/19/2020
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$50.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
